Bortezomib in combination with dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) induces long-term survival in patients with plasmablastic lymphoma: a retrospective analysis

2018 ◽  
Vol 59 (9) ◽  
pp. 2121-2127 ◽  
Author(s):  
Christopher Dittus ◽  
Natalie Grover ◽  
Steven Ellsworth ◽  
Xianming Tan ◽  
Steven I. Park
2017 ◽  
Vol 97 ◽  
pp. 750.e5-750.e10
Author(s):  
Hui Ma ◽  
Ming-Hai Wei ◽  
Hua-Min Qin ◽  
Guan-Yu Wang ◽  
Zeng-Chun Hu

2020 ◽  
Vol 52 (5) ◽  
pp. 1507-1510
Author(s):  
Javier Tejedor-Tejada ◽  
Carmen Alonso-Martín ◽  
Carolina Almohalla-Álvarez ◽  
Esteban Fuentes Valenzuela ◽  
Rodrigo Nájera Muñoz ◽  
...  

2017 ◽  
Vol 214 (2) ◽  
pp. 278-286 ◽  
Author(s):  
Pramod Kumar Mishra ◽  
Sundeep Singh Saluja ◽  
Nabi Prithiviraj ◽  
Vaibhav Varshney ◽  
Neeraj Goel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document